3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
14
Lung Neoplasms
10
Colorectal Neoplasms
8
Prostatic Neoplasms
7
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Lymphoma
3
Colonic Neoplasms
3
Urinary Bladder Neoplasms
2
Skin Carcinoma
2
Melanoma
2
Malignant Solid Neoplasm
2
Hematopoietic and Lymphatic System Neoplasm
2
Hematologic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Anatomic Stage I Breast Cancer AJCC v8
2
Advanced Malignant Solid Neoplasm
2
Triple Negative Breast Neoplasms
1
Spondylitis, Ankylosing
1
Sleep Wake Disorders
1
Rectal Neoplasms
1
Pyloric Stenosis, Hypertrophic
1
Psoriasis
1
Prostate
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Papillomavirus Infections
1
Pain
1
Overweight
1
Obesity-Related Malignant Neoplasm
1
Obesity
1
Interventions
Specimen Handling
5
Biopsy
5
Whole-Body Irradiation
3
Mycophenolic Acid
3
Cyclosporine
3
Cyclophosphamide
3
Azacitidine
3
venetoclax
2
ruxolitinib
2
fludarabine phosphate
2
decitabine and cedazuridine drug combination
2
Sirolimus
2
Melphalan
2
Injections
2
Granulocyte Colony-Stimulating Factor
2
Decitabine
2
Busulfan
2
veliparib
1
tocilizumab
1
tagraxofusp
1
posaconazole
1
peginterferon alfa-2b
1
iadademstat
1
gilteritinib
1
fludarabine
1
fedratinib
1
axatilimab
1
Tranexamic Acid
1
Topotecan
1
Tacrolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic-Myeloproliferative Diseases
×
Early Intervention, Educational
×
90 days
×
Clear all
No trials found.